Antiviral therapies.
Perry
Letitia
L
Thomson Scientific, Middlesex House, 34-42 Cleveland Street, London, W1T 4JE, UK. letitia.perry@thomson.com
Balfe
Andrew
A
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002621:Chemistry; D015507:Drugs, Investigational / Q000494:pharmacology* / Q000627:therapeutic use; D019428:HIV Integrase Inhibitors / Q000494:pharmacology; D006801:Humans; D009930:Organic Chemicals / Q000494:pharmacology; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology; D012958:Societies, Scientific; D014481:United States; D017361:Viral Nonstructural Proteins / Q000037:antagonists & inhibitors; D012697:Serine Endopeptidases; D043583:Nucleoside-Triphosphatase; D053487:DEAD-box RNA Helicases; D000085242:Viral Proteases; D012324:RNA-Dependent RNA Polymerase
D000998:Antiviral Agents; D015507:Drugs, Investigational; D019428:HIV Integrase Inhibitors; D009930:Organic Chemicals; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D018894:Reverse Transcriptase Inhibitors; D017361:Viral Nonstructural Proteins; C084422:NS3 protein, hepatitis C virus; D012697:Serine Endopeptidases; D043583:Nucleoside-Triphosphatase; D053487:DEAD-box RNA Helicases; D000085242:Viral Proteases; C087036:NS-5 protein, hepatitis C virus; D012324:RNA-Dependent RNA Polymerase